The “Cell Culture and Upstream Processing” track began many years ago as a conference of its own. In October 2004, IBC Life Sciences brought it together in Boston, MA, with three other events (“Recovery and Purification,” “Production and Economics,” and “Scaling Up from Bench to Clinic”) to create the first BPI Conference.
Just like BPI magazine’s editors, the event producers have depended on industry advisors from the beginning. Our editorial advisory board (EAB) members give generously of their time and expertise to help us keep the magazine content relevant, trustworthy, and forward-looking. Similarly, each events’ group of scientific advisors assist the producers in bringing together the best presenters and covering the most timely topics each year.
Some of our EAB members have been with us since the beginning. And some experts have come back to help IBC Life Sciences for two or more yearly events. For the “Cell Culture and Upstream Processing” track, those have included Xuejun “Sherry” Gu (Eli Lilly)...
Cell Culture and Upstream Processing
Gary Boch (Cevec Pharmaceuticals)
Custom Chemically Defined Media for CAP-T Cells
Maurizio Cattaneo (BioVolutions)
DoE for Continuous BioProcessing of Therapeutic Monoclonal Antibodies
Stephanie Dubois (ATMI LifeSciences)
Linear Scalability of Virus Production in Integrity
®
iCELLis
®
Single-Use, Fixed-Bed Bioreactors from Bench Scale to Industrial Scale
Thomas Falkman (GE Healthcare)
Assessment of Process Performance and Product Quality in High-Performing Fed-Batch Cultures
Kathleen Harrison (Frieslandcampina Domo)
Influence of Soy Protein Hydrolysates on Robustness of Cell Culture Experiments
Clint Pepper (Bend Research)
Leveraging the Modular, Automated Sampling Technology (MAST) Platform for Merging In-Line and At-Line Analytical Technologies to Gain Optimized Cell-Level “Observability” and Data-Driven Process “Guidance”
Wilson Lee (Charter Medical)
Microbial Cultivation in Different Scales in the CELL-tainer
®
Wave-Mixed Single-Use Bioreactor
Matthew Kremer (ATM...
We editors think of the “manufacturing” theme as a sort of catch-all category for technical issues that aren’t specifically protein-production or separation/purification related. For us, that has always included assay development and other analytical topics that are more product- than process-focused. For the purposes of this conference-guide supplement, however, we have developed a separate article for analytical matters.
So what falls under manufacturing? In past BPI Conferences, tracks such as “Production and Economics” and “Scaling Up from Bench to Clinic” had come from older separate conferences with the same names. They addressed many issues specific to manufacturing overall: outsourcing, operational efficiency, facilities and capacity planning, technology transfer, and single-use technology. But sometimes the lines would blur, especially between “Scaling Up” and the upstream and downstream tracks. Here we’ve tried to draw those lines as clearly as possible — as does IBC in the latest BPI Conference...
The “Recovery and Purification” track began many years ago as a conference of its own. In October 2004, IBC Life Sciences brought it together in Boston, MA, with three other events (“Cell Culture and Upstream Processing,” “Production and Economics,” and “Scaling Up from Bench to Clinic”) to create the program of the first BPI Conference and Exhibition.
Just like BPI magazine’s editors, the event producers have depended on industry advisors since the beginning. Our editorial advisory board (EAB) members give generously of their time and expertise to help us keep the magazine content relevant, trustworthy, and forward-looking. Similarly, each events’ group of scientific advisors assist the producers in bringing together the best presenters and covering the most timely topics each year.
Some of our EAB members have been with us from the beginning. And some experts have come back to help IBC Life Sciences for two or more yearly events. For the “Recovery and Purification” track, those have included
People such...
Since the concept of “well-characterized biologics” entered the biopharmaceutical industry’s vernacular late in the 20th century, increasing emphasis has been placed upon product and process characterization. Analytical laboratories have always been vital to bioprocessing, whether they were performing in-house quality assessments, preformulation and other types of product characterization, and process scale-up and optimization support, or outsourced viral safety and product testing. Recent advances in analytical technologies such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS), as well as other forms of spectroscopy, have made it possible for companies to know more about their protein products and manufacturing processes than ever before. And regulators, in turn, are asking for more data when it comes time to inspect facilities and review market applications.
What’s Different:
For most of the BPI Conference’s history, analytical topics were sprinkled throughout the program. Ce...
